Northwest Biotherapeutics (NWBO) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Northwest Biotherapeutics (NWBO) over the last 15 years, with Q3 2025 value amounting to -$0.02.
- Northwest Biotherapeutics' EPS (Weighted Average and Diluted) changed 0.0% to -$0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.06, marking a year-over-year increase of 1428.57%. This contributed to the annual value of -$68.58 for FY2024, which is 11419917.69% down from last year.
- Latest data reveals that Northwest Biotherapeutics reported EPS (Weighted Average and Diluted) of -$0.02 as of Q3 2025, which was down 0.0% from -$0.01 recorded in Q2 2025.
- Northwest Biotherapeutics' EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.01 during Q4 2023, with a 5-year trough of -$22.94 in Q4 2024.
- Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$0.02 (2021), whereas its average is -$1.48.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first skyrocketed by 9979.76% in 2022, then crashed by 22929261.99% in 2024.
- Quarter analysis of 5 years shows Northwest Biotherapeutics' EPS (Weighted Average and Diluted) stood at -$0.02 in 2021, then fell by 0.0% to -$0.02 in 2022, then surged by 50.0% to -$0.01 in 2023, then crashed by 229292.62% to -$22.94 in 2024, then surged by 99.91% to -$0.02 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.02 in Q3 2025, compared to -$0.01 in Q2 2025 and -$0.01 in Q1 2025.